JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $35

Benzinga · 2d ago
JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $14 to $35.